PubMed DOI Brancato SK, Albina JE
Tirzepatide, commercially known as Mounjaro , is administered as a subcutaneous injection
Many report saving three hundred to seven hundred dollars monthly, which makes the temporary increase in hunger and potential slight reduction in weight loss velocity acceptable trade-offs
doi:10.1002/hep.23569 Targher G, Mantovani A, Byrne CD
Precautions : Avoid in patients with a history of medullary thyroid carcinoma or MEN2
According to the letter, the product is considered an unapproved drug because it is promoted for drug-like uses on the company's website, including the following: Recalls & Warnings January 28, 2020 Weight Supplement Contains Hidden Drug On January 13, 2020, the FDA issued a warning letter to Wave Miami, LLC because the company's weight loss supplement, Lipro Dietary Capsule was found to contain the prescription medication tadalafil